Welcome to INSUPPORT®
INSUPPORT® was created by Indivior to provide information on the access and reimbursement processes on behalf of patients.
Please see the full Prescribing Information including BOXED WARNING for Sublocade (buprenorphine) injection for subcutaneous use (CIII), Important Safety Information for Sublocade and Medication Guide for SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII).
WARNING: RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY
Please see the full Prescribing Information for Suboxone (buprenorphine and naloxone) Sublingual Film (CIII), Important Safety Information for Suboxone, and Medication Guide for SUBOXONE (buprenorphine and naloxone) Sublingual Film® (CIII).
Please see the full Prescribing Information including BOXED WARNING for Perseris (risperidone) for extended-release injectable suspension and Important Safety Information for PERSERIS® (risperidone) for extended-release injectable suspension.
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA RELATED PSYCHOSIS
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. PERSERIS is not approved for the treatment of patients with dementia-related psychosis and has not been studied in this population.